Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000203800 | SCV000259334 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565332 | SCV000666177 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000565332 | SCV000684316 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-02 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004786539 | SCV005407283 | benign | Familial cancer of breast | 2024-08-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Leiden Open Variation Database | RCV001194721 | SCV001364489 | benign | not specified | 2019-08-13 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Yukihide Momozawa. |